Report Detail

Pharma & Healthcare Global Alpha Glucosidase Inhibitors Market Professional Survey Report 2019

  • RnM3789967
  • |
  • 27 September, 2019
  • |
  • Global
  • |
  • 106 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Alpha-glucosidase is an enzyme that is inhibited by alpha-glucosidase inhibitor drugs. Alpha-glucosidase helps in absorption of carbohydrates by breaking down carbohydrates into tiny sugar molecules such as glucose. The inhibition is reversible, and competitive inhibition. Alpha-glucosidase inhibitor drugs help in delaying glucose absorption and slow the digestion of carbohydrates. This results in lower rise of glucose in the blood after meals and remains effective throughout the day.
Acarbose is the most widely prescribed of the three currently available (Acarbose, Miglitol, and Voglibose) alpha‐glucosidase inhibitors and has been used in the management of hyperglycemia for years.

The global Alpha Glucosidase Inhibitors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Alpha Glucosidase Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alpha Glucosidase Inhibitors market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Alpha Glucosidase Inhibitors in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Alpha Glucosidase Inhibitors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Bayer pharma
Takeda
Sun pharma
Glenmark pharma
Torrent
Hexalag
Unichem

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Dumping Syndrome
Type 2 Diabetes

Segment by Application
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies


Table of Contents

    Executive Summary

      1 Industry Overview of Alpha Glucosidase Inhibitors

      • 1.1 Definition of Alpha Glucosidase Inhibitors
      • 1.2 Alpha Glucosidase Inhibitors Segment by Type
        • 1.2.1 Global Alpha Glucosidase Inhibitors Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Dumping Syndrome
        • 1.2.3 Type 2 Diabetes
      • 1.3 Alpha Glucosidase Inhibitors Segment by Applications
        • 1.3.1 Global Alpha Glucosidase Inhibitors Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Online Pharmacies
        • 1.3.3 Retail Pharmacies
        • 1.3.4 Hospital Pharmacies
      • 1.4 Global Alpha Glucosidase Inhibitors Overall Market
        • 1.4.1 Global Alpha Glucosidase Inhibitors Revenue (2014-2025)
        • 1.4.2 Global Alpha Glucosidase Inhibitors Production (2014-2025)
        • 1.4.3 North America Alpha Glucosidase Inhibitors Status and Prospect (2014-2025)
        • 1.4.4 Europe Alpha Glucosidase Inhibitors Status and Prospect (2014-2025)
        • 1.4.5 China Alpha Glucosidase Inhibitors Status and Prospect (2014-2025)
        • 1.4.6 Japan Alpha Glucosidase Inhibitors Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Alpha Glucosidase Inhibitors Status and Prospect (2014-2025)
        • 1.4.8 India Alpha Glucosidase Inhibitors Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Alpha Glucosidase Inhibitors
      • 2.3 Manufacturing Process Analysis of Alpha Glucosidase Inhibitors
      • 2.4 Industry Chain Structure of Alpha Glucosidase Inhibitors

      3 Development and Manufacturing Plants Analysis of Alpha Glucosidase Inhibitors

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Alpha Glucosidase Inhibitors Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Alpha Glucosidase Inhibitors
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Alpha Glucosidase Inhibitors Production and Capacity Analysis
      • 4.2 Alpha Glucosidase Inhibitors Revenue Analysis
      • 4.3 Alpha Glucosidase Inhibitors Price Analysis
      • 4.4 Market Concentration Degree

      5 Alpha Glucosidase Inhibitors Regional Market Analysis

      • 5.1 Alpha Glucosidase Inhibitors Production by Regions
        • 5.1.1 Global Alpha Glucosidase Inhibitors Production by Regions
        • 5.1.2 Global Alpha Glucosidase Inhibitors Revenue by Regions
      • 5.2 Alpha Glucosidase Inhibitors Consumption by Regions
      • 5.3 North America Alpha Glucosidase Inhibitors Market Analysis
        • 5.3.1 North America Alpha Glucosidase Inhibitors Production
        • 5.3.2 North America Alpha Glucosidase Inhibitors Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Alpha Glucosidase Inhibitors Import and Export
      • 5.4 Europe Alpha Glucosidase Inhibitors Market Analysis
        • 5.4.1 Europe Alpha Glucosidase Inhibitors Production
        • 5.4.2 Europe Alpha Glucosidase Inhibitors Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Alpha Glucosidase Inhibitors Import and Export
      • 5.5 China Alpha Glucosidase Inhibitors Market Analysis
        • 5.5.1 China Alpha Glucosidase Inhibitors Production
        • 5.5.2 China Alpha Glucosidase Inhibitors Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Alpha Glucosidase Inhibitors Import and Export
      • 5.6 Japan Alpha Glucosidase Inhibitors Market Analysis
        • 5.6.1 Japan Alpha Glucosidase Inhibitors Production
        • 5.6.2 Japan Alpha Glucosidase Inhibitors Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Alpha Glucosidase Inhibitors Import and Export
      • 5.7 Southeast Asia Alpha Glucosidase Inhibitors Market Analysis
        • 5.7.1 Southeast Asia Alpha Glucosidase Inhibitors Production
        • 5.7.2 Southeast Asia Alpha Glucosidase Inhibitors Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Alpha Glucosidase Inhibitors Import and Export
      • 5.8 India Alpha Glucosidase Inhibitors Market Analysis
        • 5.8.1 India Alpha Glucosidase Inhibitors Production
        • 5.8.2 India Alpha Glucosidase Inhibitors Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Alpha Glucosidase Inhibitors Import and Export

      6 Alpha Glucosidase Inhibitors Segment Market Analysis (by Type)

      • 6.1 Global Alpha Glucosidase Inhibitors Production by Type
      • 6.2 Global Alpha Glucosidase Inhibitors Revenue by Type
      • 6.3 Alpha Glucosidase Inhibitors Price by Type

      7 Alpha Glucosidase Inhibitors Segment Market Analysis (by Application)

      • 7.1 Global Alpha Glucosidase Inhibitors Consumption by Application
      • 7.2 Global Alpha Glucosidase Inhibitors Consumption Market Share by Application (2014-2019)

      8 Alpha Glucosidase Inhibitors Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer Alpha Glucosidase Inhibitors Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer Alpha Glucosidase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Bayer pharma
        • 8.2.1 Bayer pharma Alpha Glucosidase Inhibitors Production Sites and Area Served
        • 8.2.2 Bayer pharma Product Introduction, Application and Specification
        • 8.2.3 Bayer pharma Alpha Glucosidase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Takeda
        • 8.3.1 Takeda Alpha Glucosidase Inhibitors Production Sites and Area Served
        • 8.3.2 Takeda Product Introduction, Application and Specification
        • 8.3.3 Takeda Alpha Glucosidase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Sun pharma
        • 8.4.1 Sun pharma Alpha Glucosidase Inhibitors Production Sites and Area Served
        • 8.4.2 Sun pharma Product Introduction, Application and Specification
        • 8.4.3 Sun pharma Alpha Glucosidase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Glenmark pharma
        • 8.5.1 Glenmark pharma Alpha Glucosidase Inhibitors Production Sites and Area Served
        • 8.5.2 Glenmark pharma Product Introduction, Application and Specification
        • 8.5.3 Glenmark pharma Alpha Glucosidase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Torrent
        • 8.6.1 Torrent Alpha Glucosidase Inhibitors Production Sites and Area Served
        • 8.6.2 Torrent Product Introduction, Application and Specification
        • 8.6.3 Torrent Alpha Glucosidase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Hexalag
        • 8.7.1 Hexalag Alpha Glucosidase Inhibitors Production Sites and Area Served
        • 8.7.2 Hexalag Product Introduction, Application and Specification
        • 8.7.3 Hexalag Alpha Glucosidase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Unichem
        • 8.8.1 Unichem Alpha Glucosidase Inhibitors Production Sites and Area Served
        • 8.8.2 Unichem Product Introduction, Application and Specification
        • 8.8.3 Unichem Alpha Glucosidase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served

      9 Development Trend of Analysis of Alpha Glucosidase Inhibitors Market

      • 9.1 Global Alpha Glucosidase Inhibitors Market Trend Analysis
        • 9.1.1 Global Alpha Glucosidase Inhibitors Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Alpha Glucosidase Inhibitors Regional Market Trend
        • 9.2.1 North America Alpha Glucosidase Inhibitors Forecast 2019-2025
        • 9.2.2 Europe Alpha Glucosidase Inhibitors Forecast 2019-2025
        • 9.2.3 China Alpha Glucosidase Inhibitors Forecast 2019-2025
        • 9.2.4 Japan Alpha Glucosidase Inhibitors Forecast 2019-2025
        • 9.2.5 Southeast Asia Alpha Glucosidase Inhibitors Forecast 2019-2025
        • 9.2.6 India Alpha Glucosidase Inhibitors Forecast 2019-2025
      • 9.3 Alpha Glucosidase Inhibitors Market Trend (Product Type)
      • 9.4 Alpha Glucosidase Inhibitors Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Alpha Glucosidase Inhibitors Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Alpha Glucosidase Inhibitors. Industry analysis & Market Report on Alpha Glucosidase Inhibitors is a syndicated market report, published as Global Alpha Glucosidase Inhibitors Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Alpha Glucosidase Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,786.00
        4,179.00
        5,572.00
        3,251.50
        4,877.25
        6,503.00
        538,790.00
        808,185.00
        1,077,580.00
        292,285.00
        438,427.50
        584,570.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report